SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

FDA recall notice · announced March 11, 2026 · Anthony Trinh, 123herbals

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Notes

Distribution: USA nationwide
Lot/code information: All lots within expiry
Quantity: N/A
Status: Ongoing
Products in this recall event:
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China (D-0388-2026)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.